• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Leading New York-Based Health Agency Lazar Partners Joins FINN Partners to Create One of the Sector’s Largest Practices

Share:

September 10, 2019

Leading marketing and integrated communications firm FINN Partners Acquires Lazar Partners, Creating One of the World’s Largest Independent Health PR Practices. Pictured (L to R) are Gil Bashe, Managing Partner leading FINN’s Global Health Practice; Kristie Kuhl, Managing Partner, FINN Health; Peter Finn, Founding Partner, FINN Partners; and Fern Lazar, CEO, Lazar Partners.

Acquisition Expands FINN Capabilities in Patient Communications, Clinical Trial Recruitment, Scientific Writing, Employee Communications, Marketing, and Public and Investor Relations; Complements FINN Strengths in Advertising, Branding, CSR, and Digital and Research, and Reach in Asia, Europe, Middle East and U.S.

Global marketing and communications firm, FINN Partners, has acquired Lazar Partners, a 22-person, health-dedicated public and investor relations agency headquartered in New York City. The firm serves clients in the digital/health, health/tech, medical device and biopharma sectors

Fern Lazar, Founder and CEO of Lazar Partners, will join FINN as a managing partner and become part of the agency’s Global Health Practice leadership team, led by Gil Bashe. The addition of Lazar ranks FINN among the largest independent health agencies* with more than $30 million in revenues. The practice will grow to 150 colleagues globally and FINN to nearly 800 employees.

FINN Founding Partner Peter Finn said, “Lazar Partners is an amazing addition to FINN and demonstrates how shared values unite communities and fuel performance. This important addition shows our vision at work, focused on high-growth global sectors such as Health, Sustainability, Technology and Travel, and geographic concentration of talent and resources to best serve client interests. The Lazar team boosts our biopharma, provider and health/tech brand-building capabilities globally.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“We are passionate about our people and clients,” comments Fern Lazar, who led health and financial practices at two global PR firms before founding Lazar Partners in 2001. “Joining FINN allows us to deliver the cutting-edge services and reach of a global agency and provide our amazing team with expanded career opportunities in an entrepreneurial environment. Having admired FINN for its award-winning Health and Digital Practices, as well as a “people-first,” best place to work culture, becoming part of the firm was an easy decision to make.”

Gil Bashe, Managing Partner leading the FINN Global Health Practice, said, “The addition of Fern and the Lazar Partners team sends an important message to colleagues, clients and the industry community: everything we do must improve people’s lives. Communicators who share ideals build bridges between healers and those seeking to be healed. Lazar is a perfect fit in that mission.”

“After getting to know Peter, Gil and the FINN team, it was clear that our values and goals align,” stated Fern Lazar. “Now, by merging Lazar’s high-science offerings with the benefits of FINN resources and highly respected health expertise, we can offer more to our customers who inspire us each day. I’m excited about what the future holds for us and our clients when we unlock the potential of this powerful combination.”

Added Bashe, “I met Fern almost 20 years ago when we led different agencies with a shared client. Fern was collaborative and client-centered, and recognized that when people work together, everyone benefits. That is the very energy that makes FINN a leading agency and this relationship with Lazar Partners mutually additive.”

Lazar Partners and the FINN Health Practice share perspective on the complex U.S. health ecosystem and the belief that consumers need access to high-impact creative – across media channels – in order to make informed choices around their health and wellbeing. The two agencies have no client conflicts on their rosters, and match strengths in the digital/health, health/tech, medical device and biopharma sectors and across Food and Drug Administration regulated and direct consumer product categories.

Lazar Partners acting CFO, Seth Rosenstein, advised Lazar on the negotiations.

Date: September 10, 2019

Source: Prnews Wire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Lumen Raises $62M for Handheld Device to Measure Metabolic HealthLumen Raises $62M for Handheld Device to Measure Metabolic Health
  • Former Rep. Patrick Kennedy, Pear, Shatterproof Join Forces on New Addiction Focused DTx CoalitionFormer Rep. Patrick Kennedy, Pear, Shatterproof Join Forces on New Addiction Focused DTx Coalition
  • Kyruus Raises $42M in Series DKyruus Raises $42M in Series D
  • Working towards a future where people can live (and die) healthyWorking towards a future where people can live (and die) healthy
  • WebMD Acquires AdditudeWebMD Acquires Additude
  • Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma CompanyBristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company
  • Alfie Health Raises $2.1M for AI-Powered, Virtual Obesity ClinicAlfie Health Raises $2.1M for AI-Powered, Virtual Obesity Clinic
  • NeoGenomics Completes Inivata Acquisition – Combining Best-in-Class Liquid Biopsy Technology with Leading Community Oncology PlatformNeoGenomics Completes Inivata Acquisition – Combining Best-in-Class Liquid Biopsy Technology with Leading Community Oncology Platform

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications